Difficulties are increased for non-complied E-Pharmacies when Drugs Controller General of India (DCGI) asked all states and union territories to stop online sale of medicines without licence and the competent authority has been directed to stall such online sales forthwith as per ordered by Delhi Highcourt.
Pharmacists, all over the India are opposing Union Health Ministry’s Notification dated 06th November, 2019 regarding proposal to amendment in Schedule K of the Drugs and Cosmetics Rules which is allowing unqualified or lesser qualified workers to dispatch medicines.
The Union Cabinet chaired by the Prime Minister Shri Narendra Modi has approved the Memorandum of Understanding (MoU) between India and Brazil in the field of Health and Medicine. The MoU is expected to be signed in November, 2019.
President of Gujarat state pharmacy council (GSPC), Mr. Montu Patel elected as member of Pharmacy council of India (PCI), Delhi. He became forth member from Gujarat to offer his services under PCI. Currently, Dr. NR Seth (Vice Chancellor, Gujarat Technological University), Dr. CN Patel (Professor & Principal, Shri Sarvajanik Pharmacy College, Mehsana) and Dr. HG Koshia (Commissioner, Food & Drugs Control Administration, Gujarat) are working members of PCI.
DCGI asked manufacturers of Ranitidine API & formulations to verify their products and take appropriate measures to ensure patient safety after news of ranitidine contamination came in picture.
Pharmacovigilance Programme of India (PvPI) urges all stakeholders to report all the adverse events associated with nutraceuticals/ health supplements and food supplements.
In a major health and wellness initiative for the country, the Union Cabinet chaired by the Prime Minister Shri Narendra Modi has approved the Promulgation of the Prohibition of Electronic Cigarettes (production, manufacture, import, export, transport, sale, distribution, storage and advertisement) Ordinance, 2019.
The Pharmacy Council of India (PCI) has issued a clarification on the moratorium related to opening of new pharmacy colleges in the country from 2020-21.
The ceiling price of Tenofovir 300mg tablet has been increased by 4.2662% on the basis of the annual increase in Wholesale Price Index (WPI), and has been notified at Rs. 46.18.
Department of Pharmaceuticals (DoP) has rejected Cipla's plea against decision of National Pharmaceutical Pricing Authority (NPPA) for fixing the retail prices of Emtricitabine+ Tenofovir Alafenamide tablet (brand Tafmune - EM) containing Emtricitabine IP 200mg, Tenofovir Alafenamide Hemifumarate eq. to Tenofovir Alafenamide 25mg.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
